Concizumab Disease Interactions
There is 1 disease interaction with concizumab.
Concizumab (applies to concizumab) thromboembolism
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Cardiovascular Disease, Peripheral Arterial Disease, Renal Artery Atherosclerosis, Cerebral Vascular Disorder, History - Cerebrovascular Disease, History - Myocardial Infarction, Disseminated Intravascular Coagulation, Thrombotic/Thromboembolic Disorder, History - Thrombotic/Thromboembolic Disorder, Septicemia
Venous and arterial thromboembolic events have occurred with use of concizumab. Patients with conditions in which tissue factor is overexpressed, such as atherosclerotic disease, crush injury, cancer, disseminated intravascular coagulation, thrombotic microangiopathy, or septicemia may be increased risk for thromboembolism. Closely monitor patients for thromboembolic events during therapy with concizumab.
Switch to professional interaction data
Concizumab drug interactions
There are 9 drug interactions with concizumab.
Report options
More about concizumab
- concizumab consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.